Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Randy Vogenberg

Showing results (11-20 of 82) with videos related to

Pageof 9
Sort By:
Biotechnology Healthcare|April 6, 2012
Turning a blind eye to valueF Randy Vogenberg
Managed Care (Langhorne, Pa.)|June 13, 2019
As Health Care Landscape Shifts, Stakeholders Need To Shift as WellF Randy Vogenberg
Biotechnology Healthcare|December 26, 2012
Defined contribution and alternative care meet personalized medicineF Randy Vogenberg
American Health & Drug Benefits|April 12, 2019
US Healthcare Trends and Contradictions in 2019F Randy Vogenberg
American Health & Drug Benefits|August 16, 2014
Predictive and prognostic models: implications for healthcare decision-making in a modern recessionF Randy Vogenberg
American Health & Drug Benefits|August 17, 2014
Disruptive innovation: value-based health plansF Randy Vogenberg
P & T : a Peer-Reviewed Journal for Formulary Management|February 9, 2010
Comparative effectiveness research: valuable insight or government intrusion?F Randy Vogenberg
Managed Care (Langhorne, Pa.)|September 8, 2009
Use a value-based strategy for biotech medicationsF Randy Vogenberg
American Health & Drug Benefits|May 7, 2015
Key Strategic Trends that Impact Healthcare Decision-Making and Stakeholder Roles in the New MarketplaceJohn Santilli, F Randy Vogenberg
P & T : a Peer-Reviewed Journal for Formulary Management|June 30, 2009
Economic instability and its impact on decision making in health careF Randy Vogenberg, Stephen Cutts
Pageof 9

Showing results (11-20 of 82) with videos related to

Sort By:
Pageof 9
Biotechnology Healthcare|April 6, 2012
Turning a blind eye to valueF Randy Vogenberg
Managed Care (Langhorne, Pa.)|June 13, 2019
As Health Care Landscape Shifts, Stakeholders Need To Shift as WellF Randy Vogenberg
Biotechnology Healthcare|December 26, 2012
Defined contribution and alternative care meet personalized medicineF Randy Vogenberg
American Health & Drug Benefits|April 12, 2019
US Healthcare Trends and Contradictions in 2019F Randy Vogenberg
American Health & Drug Benefits|August 16, 2014
Predictive and prognostic models: implications for healthcare decision-making in a modern recessionF Randy Vogenberg
American Health & Drug Benefits|August 17, 2014
Disruptive innovation: value-based health plansF Randy Vogenberg
P & T : a Peer-Reviewed Journal for Formulary Management|February 9, 2010
Comparative effectiveness research: valuable insight or government intrusion?F Randy Vogenberg
Managed Care (Langhorne, Pa.)|September 8, 2009
Use a value-based strategy for biotech medicationsF Randy Vogenberg
American Health & Drug Benefits|May 7, 2015
Key Strategic Trends that Impact Healthcare Decision-Making and Stakeholder Roles in the New MarketplaceJohn Santilli, F Randy Vogenberg
P & T : a Peer-Reviewed Journal for Formulary Management|June 30, 2009
Economic instability and its impact on decision making in health careF Randy Vogenberg, Stephen Cutts
Pageof 9